Mai Abdelnabi, MD
Rheumatology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 9
Offices
9 locations · North East Medical Services · 143 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abdelnabi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$2,785
Medicare paid this office $2,785 for 79 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of needle into vein for collection of blood sample | 70 | $682 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 34 | $419 | $8 |
| Liver function blood test panel | 28 | $401 | $8 |
| Uric acid level, blood | 28 | $217 | $4 |
| Blood creatinine level | 26 | $206 | $5 |
See all 7 services
| Insertion of needle into vein for collection of blood sample | 70 | $682 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 34 | $419 | $8 |
| Liver function blood test panel | 28 | $401 | $8 |
| Uric acid level, blood | 28 | $217 | $4 |
| Blood creatinine level | 26 | $206 | $5 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 24 | $121 | $4 |
| Manual urinalysis test with examination using microscope, automated | 17 | $53 | $3 |
Who their Medicare patients are
79 Original Medicare patients in 2024. Average age 72 · Women 73% · Health risk score 0.93. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 67% · Diabetes 35% · Chronic kidney disease 28%.
The office billed $11,368, Medicare allowed $2,785 and paid $2,785; for 417 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 79 | 417 | 72 | 0.93 | $11,368 | $2,785 |
| 2023 | 77 | 421 | 72 | 0.89 | $11,812 | $2,963 |
| 2022 | 37 | 221 | 71 | 0.88 | $5,925 | $1,266 |
| 2021 | 202 | 13,038 | 69 | 1.36 | $829,848 | $275,294 |
| 2020 | 152 | 15,152 | 72 | 1.25 | $785,690 | $314,679 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Insertion of needle into vein for collection of blood sample | 66 | $659 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 26 | $358 | $8 |
| Liver function blood test panel | 24 | $328 | $8 |
| Blood creatinine level | 35 | $271 | $5 |
| Hepatitis c antibody measurement | 15 | $210 | $14 |
| Uric acid level, blood | 21 | $182 | $4 |
| Hepatitis b core antibody measurement | 12 | $142 | $12 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 13 | $132 | $10 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 27 | $130 | $4 |
| Manual urinalysis test with examination using microscope, automated | 19 | $81 | $3 |
2022: 5 services
| Liver function blood test panel | 11 | $241 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 13 | $191 | $8 |
| Insertion of needle into vein for collection of blood sample | 36 | $189 | $3 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 18 | $84 | $4 |
| Uric acid level, blood | 16 | $71 | $4 |
2021: 16 services
| Injection, infliximab, excludes biosimilar, 10 mg | 11 | $30,688 | None |
| Injection, golimumab, 1 mg, for intravenous use | 11 | $25,284 | None |
| Long return visit (40+ min) | 47 | $6,524 | $136 |
| Administration of chemotherapy into vein, 1 hour or less | 25 | $3,166 | $106 |
| Return visit (30+ min) | 35 | $2,546 | $71 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 28 | $2,267 | $54 |
| New patient visit (45+ min) | 15 | $1,671 | $111 |
| Administration of chemotherapy into vein, each additional hour | 23 | $1,039 | $24 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 80 | $675 | $8 |
| Liver function blood test panel | 57 | $497 | $8 |
| Insertion of needle into vein for collection of blood sample | 92 | $320 | $3 |
| Blood creatinine level | 57 | $312 | $5 |
| Injection of drug or substance under skin or into muscle | 12 | $273 | $11 |
| Blood test, comprehensive group of blood chemicals | 16 | $169 | $11 |
| Measurement c-reactive protein for detection of infection or inflammation | 31 | $166 | $5 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 30 | $84 | $3 |
2020: 23 services
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 19 | $84,830 | None |
| Injection, infliximab, excludes biosimilar, 10 mg | 25 | $59,049 | None |
| Injection, denosumab, 1 mg | 13 | $12,557 | None |
| Administration of chemotherapy into vein, 1 hour or less | 62 | $7,270 | $105 |
| New patient visit (45+ min) | 25 | $3,203 | $128 |
| Return visit (30+ min) | 26 | $2,370 | $85 |
| Administration of chemotherapy into vein, each additional hour | 44 | $2,218 | $23 |
| Short return visit (20+ min) | 20 | $1,281 | $58 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 19 | $1,024 | $54 |
| Vitamin d-3 level | 22 | $681 | $30 |
| Parathormone (parathyroid hormone) level | 14 | $660 | $41 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 11 | $612 | $51 |
| Dxa bone density measurement of hip, pelvis, spine | 13 | $489 | $38 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 45 | $366 | $8 |
| Blood test, comprehensive group of blood chemicals | 34 | $349 | $10 |
| Injection of additional new drug or substance into vein | 13 | $288 | $12 |
| Injection of drug or substance under skin or into muscle | 18 | $254 | $11 |
| Blood test, thyroid stimulating hormone (tsh) | 14 | $235 | $17 |
| Insertion of needle into vein for collection of blood sample | 56 | $180 | $3 |
| Liver function blood test panel | 17 | $139 | $8 |
| Measurement c-reactive protein for detection of infection or inflammation | 18 | $109 | $5 |
| Blood creatinine level | 18 | $92 | $5 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 18 | $57 | $3 |
Medicaid work
$339,193 in 2024
Medicaid paid $339,193 for 7,387 billed services this clinician did in 2024, up to 117 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,870 | $325,772 |
| Long return visit (40+ min) | 467 | $5,351 |
| Short return visit (20+ min) | 1,200 | $4,703 |
| Return visit (30+ min) | 510 | $2,422 |
| Short return visit | 612 | $944 |
| Arthrocentesis and injection of knee joint | 18 | $0 |
| BODY MASS INDEX DOCD | 990 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 647 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 62 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 92 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 826 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 93 | $0 |
| 2024 | 7,387 | 12 | 117 | $339,193 |
| 2023 | 3,669 | 10 | 82 | $212,287 |
| 2022 | 1,476 | 7 | 49 | $49,534 |
| 2021 | 12 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,353 | $209,704 |
| Return visit (30+ min) | 478 | $1,000 |
| Long return visit (40+ min) | 384 | $901 |
| Short return visit (20+ min) | 705 | $606 |
| Short return visit | 143 | $77 |
| BODY MASS INDEX DOCD | 77 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 231 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 258 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 26 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 296 | $49,392 |
| Long return visit (40+ min) | 84 | $100 |
| Short return visit (20+ min) | 226 | $42 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 238 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 281 | $0 |
| Return visit (30+ min) | 338 | $0 |
2021
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 12 | $0 |
Drugs they prescribed that Part D paid
$468,291
Pharmacies billed $468,291 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 707) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
633 generic and 74 brand-name prescriptions · $468,291 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 27 | $215,952 | $7,998 |
| Rinvoq | 14 | $79,557 | $5,683 |
| Prolia | 14 | $20,377 | $1,456 |
| Hydroxychloroquine Sulfate | 89 | $3,341 | $38 |
| Leflunomide | 34 | $2,419 | $71 |
See all 13 drugs
| Humira(Cf) | 27 | $215,952 | $7,998 |
| Rinvoq | 14 | $79,557 | $5,683 |
| Prolia | 14 | $20,377 | $1,456 |
| Hydroxychloroquine Sulfate | 89 | $3,341 | $38 |
| Leflunomide | 34 | $2,419 | $71 |
| Colchicine | 45 | $2,182 | $48 |
| Methotrexate | 54 | $1,310 | $24 |
| Celecoxib | 51 | $1,273 | $25 |
| Meloxicam | 195 | $914 | $5 |
| Gabapentin | 26 | $762 | $29 |
| Allopurinol | 60 | $628 | $10 |
| Alendronate | 13 | $184 | $14 |
| Prednisone | 29 | $104 | $4 |
Year by year
| 2024 | 707 | 223 | 0% (0) | 10% | $468,291 |
| 2023 | 510 | 159 | None | 11% | $428,258 |
| 2022 | 149 | 59 | 0% (0) | 13% | $134,416 |
| 2021 | 367 | 156 | None | 23% | $447,984 |
| 2020 | 451 | 103 | 4% (16) | 15% | $223,296 |
| 2019 | 589 | 135 | 3% (19) | 24% | $329,706 |
| 2018 | 614 | 140 | 5% (30) | 19% | $150,974 |
| 2017 | 522 | 77 | 5% (26) | 25% | $52,246 |
| 2016 | 400 | 51 | 6% (22) | None | $20,274 |
| 2015 | 124 | 39 | 9% (11) | None | $7,952 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Humira(Cf) | 31 | $300,562 | $9,696 |
| Rinvoq | 15 | $100,228 | $6,682 |
| Celecoxib | 27 | $3,127 | $116 |
| Colchicine | 32 | $3,112 | $97 |
| Hydroxychloroquine Sulfate | 48 | $2,943 | $61 |
| Leflunomide | 31 | $2,115 | $68 |
| Meloxicam | 136 | $1,836 | $13 |
| Methotrexate | 24 | $1,019 | $42 |
| Diclofenac | 25 | $655 | $26 |
| Prednisone | 39 | $512 | $13 |
| Allopurinol | 32 | $489 | $15 |
| Gabapentin | 15 | $405 | $27 |
| Alendronate | 13 | $327 | $25 |
2022: 6 drugs
| Humira(Cf) | 11 | $88,768 | $8,070 |
| Hydroxychloroquine Sulfate | 19 | $2,078 | $109 |
| Leflunomide | 15 | $1,749 | $117 |
| Methotrexate | 17 | $955 | $56 |
| Meloxicam | 36 | $123 | $3 |
| Prednisone | 17 | $121 | $7 |
2021: 7 drugs
| Rinvoq | 26 | $150,541 | $5,790 |
| Humira(Cf) | 16 | $114,230 | $7,139 |
| Hydroxychloroquine Sulfate | 53 | $2,969 | $56 |
| Leflunomide | 29 | $2,044 | $70 |
| Methotrexate | 62 | $1,626 | $26 |
| Prednisone | 70 | $696 | $10 |
| Meloxicam | 13 | $45 | $3 |
2020: 13 drugs
| Humira | 14 | $78,636 | $5,617 |
| Hydroxychloroquine Sulfate | 80 | $8,807 | $110 |
| Methotrexate | 56 | $4,560 | $81 |
| Leflunomide | 11 | $2,033 | $185 |
| Celecoxib | 19 | $1,582 | $83 |
| Prednisone | 61 | $1,013 | $17 |
| Sulfasalazine | 25 | $925 | $37 |
| Diclofenac | 27 | $826 | $31 |
| Mycophenolate Mofetil | 11 | $704 | $64 |
| Azathioprine | 11 | $393 | $36 |
| Alendronate | 20 | $298 | $15 |
| Gabapentin | 11 | $215 | $20 |
| Meloxicam | 12 | $91 | $8 |
2019: 16 drugs
| Humira | 15 | $78,662 | $5,244 |
| Hydroxychloroquine Sulfate | 84 | $12,674 | $151 |
| Methotrexate | 75 | $4,827 | $64 |
| Leflunomide | 24 | $4,562 | $190 |
| Celecoxib | 20 | $2,174 | $109 |
| Azathioprine | 25 | $1,783 | $71 |
| Prednisone | 73 | $1,381 | $19 |
| Diclofenac | 28 | $1,254 | $45 |
| Sulfasalazine | 24 | $1,168 | $49 |
| Mycophenolate Mofetil | 14 | $952 | $68 |
| Leucovorin | 15 | $874 | $58 |
| Hydrocodone-Acetaminophen | 12 | $472 | $39 |
| Allopurinol | 16 | $293 | $18 |
| Alendronate | 18 | $287 | $16 |
| Meloxicam | 18 | $203 | $11 |
| Gabapentin | 13 | $115 | $9 |
2018: 13 drugs
| Leflunomide | 12 | $2,795 | $233 |
| Levemir | 12 | $2,252 | $188 |
| Methotrexate | 32 | $2,113 | $66 |
| Hydroxychloroquine Sulfate | 14 | $1,745 | $125 |
| Gabapentin | 26 | $1,150 | $44 |
| Prednisone | 31 | $450 | $15 |
| Sulfasalazine | 11 | $332 | $30 |
| Fluticasone Propionate | 24 | $198 | $8 |
| Omeprazole | 20 | $151 | $8 |
| Furosemide | 12 | $102 | $8 |
| Lisinopril | 14 | $76 | $5 |
| Losartan | 14 | $57 | $4 |
| Amlodipine Besylate | 12 | $51 | $4 |
2017: 12 drugs
| Lantus | 15 | $7,606 | $507 |
| Proair Hfa | 11 | $633 | $58 |
| Lisinopril | 28 | $246 | $9 |
| Oxycodone-Acetaminophen | 11 | $232 | $21 |
| Omeprazole | 16 | $181 | $11 |
| Atorvastatin | 11 | $178 | $16 |
| Gabapentin | 16 | $158 | $10 |
| Losartan | 12 | $157 | $13 |
| Fluticasone Propionate | 17 | $124 | $7 |
| Promethazine | 13 | $118 | $9 |
| Furosemide | 15 | $78 | $5 |
| Hydrochlorothiazide | 11 | $72 | $7 |
2016: 10 drugs
| Lantus | 18 | $4,506 | $250 |
| Proair Hfa | 11 | $591 | $54 |
| Metoprolol | 22 | $315 | $14 |
| Atorvastatin | 13 | $219 | $17 |
| Gabapentin | 24 | $168 | $7 |
| Lisinopril | 22 | $156 | $7 |
| Hydrochlorothiazide | 20 | $129 | $6 |
| Amlodipine Besylate | 12 | $114 | $9 |
| Simvastatin | 13 | $68 | $5 |
| Furosemide | 12 | $46 | $4 |
2015: 1 drug
| Gabapentin | 11 | $228 | $21 |
Money from drug and device companies
$107 in 2025
| 2025 | 1 | 1 | None | $107 |
| 2024 | 2 | 2 | None | $202 |
| 2023 | 3 | 4 | None | $305 |
| 2020 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Bimzelx | $107 | 1 payment
|
See the published payment
| Ucb | Meals · 2025-03-05 | Bimzelx | $107 |
See earlier years (2024, 2023, 2020)
2024: $202
| Amgen | Tavneos | $126 | 1 payment
|
| Ucb | Bimzelx | $76 | 1 payment
|
2023: $305
| GlaxoSmithKline | None | $147 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $134 | 1 payment
|
| AbbVie | Rinvoq | $23 | 1 payment
|
2020: $23
| E.R. Squibb & Sons L.L.C. | Orencia | $23 | 1 payment
|
Professional record
- NPI
- 1013394980
- Licence
- NC 202002597, WI 75418-20
- Trained
- George Washington University School of Medicine, 2015
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- NC 1013394980
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 1520 Stockton St, San Francisco, CA, 94133
- NPI first listed
- 2015-04-30
- NPI last updated
- 2024-04-10
- NPI record certified
- 2024-04-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1918 Randolph Rd Ste 600, Charlotte, NC, 28207 · 1215 Lee St, Charlottesville, VA, 22908 · 2727 Plaza Dr, Wausau, WI, 54401